[시장보고서]말초신경병증 치료 시장 : 유형, 치료(약물 요법, 비약물 요법), 유통 채널별, 지역별

	말초신경병증 치료 시장 : 유형, 치료(약물 요법, 비약물 요법), 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2020-2027년) Peripheral Neuropathy Treatment Market, by Type, by Treatment (Pharmacological Therapies and Non-pharmacological Therapies, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
리서치사	Coherent Market Insights
발행일	2020년 12월	상품 코드	980048
페이지 정보	영문
가격	US $ 4,500 ￦ 5,431,000 PPT Turned PDF (Single User License) US $ 7,000 ￦ 8,449,000 PPT Turned PDF (Multi-user License) US $ 10,000 ￦ 12,070,000 PPT Turned PDF (Enterprise User License)

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 말초신경병증 치료 시장의 성장요인으로 고령화 인구의 증가를 들 수 있습니다. 2018년 2월에 세계보건기구(WHO)가 발표한 기사에 따르면 2015-2050년 세계 고령 인구의 비율은 12%에서 22%로 거의 배증한다고 보고되고 있습니다. 또한 당뇨병의 증례 증가는 이 시장의 성장을 촉진할 것으로 예상되고 있습니다. 국제당뇨병연맹(IDF)이 발표한 기사에 따르면 2017년 18-99세 당뇨병 환자의 추정수는 세계에서 약 4억 2,500만 명입니다.

세계의 말초신경병증 치료 시장에 대해 조사했으며, 시장 규모 및 점유율, 시장 기회 및 동향, 성장 및 억제요인, 유형·치료·유통 채널·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

히트맵 분석
시장 점유율 분석
- Abbott
- Bristol Myers Squibb
- Cipla Limited
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Lupin Limited
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Dr. Reddy's Laboratories
- Mylan NV
- Johnson & Johnson Services Inc.
- Teva Pharmaceutical Industries Ltd.

제10장 애널리스트의 견해

제11장 섹션

KSA 21.01.13

Title:
Peripheral Neuropathy Treatment Market, by Type (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), by Treatment (Pharmacological Therapies (Pain Relievers, Anti-seizure Medications, and Antidepressants) and Non-pharmacological Therapies (Transcutaneous Electrical Nerve Stimulation, Plasma Exchange and Intravenous Immune Globulin, and Others), by Distribution Channel (Hospitals and Clinics, Ambulatory Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Peripheral neuropathy is a disorder that affects the peripheral nerves. Peripheral neuropathy has a variety of systemic, metabolic, and toxic causes, for instance diabetes in metabolic cause. The most common treatable causes include diabetes mellitus, hypothyroidism, and nutritional deficiencies. The diagnosis require careful clinical assessment, judicious laboratory testing, and electro diagnostic studies or nerve biopsy, if the diagnosis remains unclear.

Market Dynamics

Rising aging population is expected to drive the global peripheral neuropathy treatment market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, reports that between 2015 and 2050, the proportion of the worldwide geriatric population will nearly double from 12% to 22%.

Moreover, rising diabetic cases is expected to drive the market growth. For instance, according to an article published by the International Diabetes Federation (IDF), in 2017, the estimated number of 18 to 99 year old diabetic patients was around 425 million globally.

researched

medicinal properties of cannabis and its derivatives are widely

Researched

Medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

Key features of the study:

This report provides in-depth analysis of the global peripheral neuropathy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peripheral neuropathy treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Abbott, Bristol Myers Squibb, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc., Lupin Limited, Merck and Co. Inc., Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories, Mylan NV, Johnson & Johnson Services Inc., and Teva Pharmaceutical Industries Ltd, among others.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global peripheral neuropathy treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral neuropathy treatment market.

Detailed Segmentation:

Global Peripheral Neuropathy Treatment Market, By Type:
- Diabetic Peripheral Neuropathy
- Chemotherapy-induced Peripheral Neuropathy
- Idiopathic Peripheral Neuropathy
- Others
Global Peripheral Neuropathy Treatment Market, By Treatment:
- Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
- Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
Global Peripheral Neuropathy Treatment Market, By Distribution Channel:
- Hospitals and Clinics
- Ambulatory Centers
- Others
Global Peripheral Neuropathy Treatment Market, By Region:
- North America
  - By Type:
  - Diabetic Peripheral Neuropathy
  - Chemotherapy-induced Peripheral Neuropathy
  - Idiopathic Peripheral Neuropathy
  - Others
  - By Treatment:
  - Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
  - Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
  - By Distribution Channel:
  - Hospitals and Clinics
  - Ambulatory Centers
  - Others
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Type:
  - Diabetic Peripheral Neuropathy
  - Chemotherapy-induced Peripheral Neuropathy
  - Idiopathic Peripheral Neuropathy
  - Others
  - By Treatment:
  - By Treatment:
  - Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
  - Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
  - By Distribution Channel:
  - Hospitals and Clinics
  - Ambulatory Centers
  - Others
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Type:
  - Diabetic Peripheral Neuropathy
  - Chemotherapy-induced Peripheral Neuropathy
  - Idiopathic Peripheral Neuropathy
  - Others
  - By Treatment:
  - Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
  - Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
  - By Distribution Channel:
  - Hospitals and Clinics
  - Ambulatory Centers
  - Others
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Type:
  - Diabetic Peripheral Neuropathy
  - Chemotherapy-induced Peripheral Neuropathy
  - Idiopathic Peripheral Neuropathy
  - Others
  - By Treatment:
  - Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
  - Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
  - By Distribution Channel:
  - Hospitals and Clinics
  - Ambulatory Centers
  - Others
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Type:
  - Diabetic Peripheral Neuropathy
  - Chemotherapy-induced Peripheral Neuropathy
  - Idiopathic Peripheral Neuropathy
  - Others
  - By Treatment:
  - Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
  - Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
  - By Distribution Channel:
  - Hospitals and Clinics
  - Ambulatory Centers
  - Others
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Type:
  - Diabetic Peripheral Neuropathy
  - Chemotherapy-induced Peripheral Neuropathy
  - Idiopathic Peripheral Neuropathy
  - Others
  - By Treatment:
  - Pharmacological Therapies
  - Pain Relievers
  - Anti-seizure Medications
  - Antidepressants
  - Non-pharmacological Therapies
  - Transcutaneous Electrical Nerve Stimulation
  - Plasma Exchange and Intravenous Immune Globulin
  - Others
  - By Distribution Channel:
  - Hospitals and Clinics
  - Ambulatory Centers
  - Others
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Abbott*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Bristol Myers Squibb
- Cipla Limited
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Lupin Limited
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Dr. Reddy's Laboratories
- Mylan NV
- Johnson & Johnson Services Inc.
- Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Peripheral Neuropathy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Market Scenario
Impact of COVID-19 Market on the Peripheral Neuropathy Treatment Products

5. Global Peripheral Neuropathy Treatment Market, By Type, 2016 - 2027, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 - 2027
- Segment Trends
Diabetic Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
Chemotherapy-induced Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
Idiopathic Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Peripheral Neuropathy Treatment Market, By Treatment, 2016 - 2027, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 - 2027
- Segment Trends
Pharmacological Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
- Pain Relievers
- Anti-seizure Medications
- Antidepressants
Non-pharmacological Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
- Transcutaneous Electrical Nerve Stimulation
- Plasma Exchange and Intravenous Immune Globulin
- Others

7. Global Peripheral Neuropathy Treatment Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 - 2027
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
Ambulatory Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Peripheral Neuropathy Treatment Market, By Region, 2016 - 2027, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2027
North America
- Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Abbott
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol Myers Squibb
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck and Co. Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mylan NV
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson Services Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies

10. Analyst Views

11. Section

References
Research Methodology
About us and Sales Contact

F A Q

말초신경병증 치료 시장 : 유형, 치료(약물 요법, 비약물 요법), 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2020-2027년)

Peripheral Neuropathy Treatment Market, by Type, by Treatment (Pharmacological Therapies and Non-pharmacological Therapies, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

목차

제1장 조사 목적·전제조건

제2장 시장의 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 COVID-19 팬데믹의 영향

제5장 시장 분석 : 유형별(2016-2027)

제6장 시장 분석 : 치료별(2016-2027)

제7장 시장 분석 : 유통 채널별(2016-2027)

제8장 시장 분석 : 지역별(2016-2027)

제9장 경쟁 구도

제10장 애널리스트의 견해

제11장 섹션

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Peripheral Neuropathy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Peripheral Neuropathy Treatment Market, By Type, 2016 - 2027, (US$ Mn)

6. Global Peripheral Neuropathy Treatment Market, By Treatment, 2016 - 2027, (US$ Mn)

7. Global Peripheral Neuropathy Treatment Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

8. Global Peripheral Neuropathy Treatment Market, By Region, 2016 - 2027, (US$ Mn)

9. Competitive Landscape

10. Analyst Views

11. Section